Barclays »

Korro Bio shares owned by Barclays

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Barclays

Quarter filed Position value Share count Share price at filing
2025-03-31 $126k 7.2k 17.40
2024-12-31 $395k 10k 38.04

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Driehaus Capital Management
FMR
Point72 Asset Management
Cormorant Asset Management
BlackRock
Siren
TCG Crossover Management
Vanguard Group
Qiming U.S. Ventures Management
Tri Locum Partners
72 Investment Holdings
Polar Capital Holdings
Millennium Management

View all funds holding Korro Bio